Last reviewed · How we verify
NCT06848673: TBEye
Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI
Phase 2 trial testing Office-Based Vergence/Accommodative Therapy with Movement (OBVAM) in Convergence Insufficiency in 100 participants. Not yet recruiting.
30 April 2028
Quick facts
| Lead sponsor | Salus University |
|---|---|
| Phase | Phase 2 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 November 2026 |
| Primary completion | 30 April 2028 |
| Estimated completion | 30 September 2028 |
Drugs / interventions tested
- Office-Based Vergence/Accommodative Therapy with Movement (OBVAM)
Conditions studied
- Convergence Insufficiency — all drugs for Convergence Insufficiency →
Sponsor
Salus University
Who can join
Adults 18 to 35, any sex, with Convergence Insufficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The design of this project is a pilot study, a type of feasibility study conducted in preparation for subsequent RCTs that will assess the effectiveness of office-based vergence/accommodative therapy with movement (OBVAM) for mTBI-related convergence insufficiency.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06848673
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Convergence Insufficiency
Currently open trials in the same condition.
- NCT06886737 — Home-based Vision Therapy · Phase 1 · recruiting
- NCT06913829 — Efficacy Of Pencil Pushup Exercise Vs Base Out Exercising Prism's In Patient With Convergence Insufficiency · NA · active not recruiting
- NCT05877560 — Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency · NA · recruiting
- NCT06105892 — Eye Recovery Automation for Post Injury Dysfunction (iRAPID) · NA · recruiting
Other Salus University trials
Trials by the same sponsor.
- NCT07282691 — Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders · recruiting
- NCT05825248 — Comparing Two Protocols to Improve Reflex Integration and Functional Performance · NA · unknown
- NCT05242575 — The Influence of Immersive Virtual Field Trips on Academic Vocabulary · NA · completed
- NCT04185324 — Efficacy of an Intervention to Teach Zippering: A Two-Group Control Study · NA · completed
- NCT03780205 — Bilateral and Unilateral Amblyopia Treatment Study · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06848673 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Salus University
- Last refreshed: 27 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06848673.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing